Go Pro

Trellus Health (TRLS) Competitors

GBX 0.12 0.00 (0.00%)
As of 09/10/2026

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

Should you buy Trellus Health stock or one of its competitors? Trellus Health's main competitors and comparable companies include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Trellus Health compare to IQ-AI?

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

IQ-AI has a beta of 2.25, indicating that its stock price is 125% more volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, indicating that its stock price is 151% more volatile than the broader market.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -6,826.32%-49.78%-22.76%

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

1.6% of Trellus Health shares are held by institutional investors. 66.0% of IQ-AI shares are held by insiders. Comparatively, 9.6% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

How does Trellus Health compare to DeepVerge?

Trellus Health (LON:TRLS) and DeepVerge (LON:DVRG) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

DeepVerge has a net margin of -19.81% compared to Trellus Health's net margin of -6,826.32%. DeepVerge's return on equity of -10.27% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
DeepVerge -19.81%-10.27%-5.56%

Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

DeepVerge has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
DeepVerge£12.41M0.00-£2.46M-£0.01N/A

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
DeepVerge Neutral

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 4.2% of DeepVerge shares are held by institutional investors. 9.6% of Trellus Health shares are held by company insiders. Comparatively, 9.5% of DeepVerge shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

DeepVerge beats Trellus Health on 7 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Sensyne Health?

Trellus Health (LON:TRLS) and Sensyne Health (LON:SENS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

1.6% of Trellus Health shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Sensyne Health Neutral

Sensyne Health has a net margin of 0.00% compared to Trellus Health's net margin of -6,826.32%. Sensyne Health's return on equity of 0.00% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
Sensyne Health N/A N/A N/A

Sensyne Health has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

Summary

Sensyne Health beats Trellus Health on 5 of the 8 factors compared between the two stocks.

How does Trellus Health compare to EMIS Group?

EMIS Group (LON:EMIS) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

In the previous week, EMIS Group's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
EMIS Group Neutral
Trellus Health Neutral

EMIS Group has a beta of -0.13, meaning that its share price is 113% less volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market.

105.6% of EMIS Group shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 3.6% of EMIS Group shares are owned by company insiders. Comparatively, 9.6% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

EMIS Group has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EMIS Group£176.86M0.00£30.48M£0.47N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

EMIS Group has a net margin of 17.23% compared to Trellus Health's net margin of -6,826.32%. EMIS Group's return on equity of 23.17% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
EMIS Group17.23% 23.17% 7.99%
Trellus Health -6,826.32%-49.78%-22.76%

Summary

EMIS Group beats Trellus Health on 8 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Craneware?

Trellus Health (LON:TRLS) and Craneware (LON:CRW) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

Craneware has a net margin of 10.63% compared to Trellus Health's net margin of -6,826.32%. Craneware's return on equity of 6.65% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
Craneware 10.63%6.65%2.28%

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Craneware£211.33M2.14£14.27M£62.9021.05

Craneware has a consensus target price of GBX 2,222.75, suggesting a potential upside of 67.88%. Given Craneware's stronger consensus rating and higher probable upside, analysts clearly believe Craneware is more favorable than Trellus Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Craneware
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 33.6% of Craneware shares are held by institutional investors. 9.6% of Trellus Health shares are held by insiders. Comparatively, 10.3% of Craneware shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Craneware had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Trellus Health. Craneware's average media sentiment score of 0.67 beat Trellus Health's score of 0.00 indicating that Craneware is being referred to more favorably in the news media.

Company Overall Sentiment
Trellus Health Neutral
Craneware Positive

Trellus Health has a beta of 2.509, suggesting that its share price is 151% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

Summary

Craneware beats Trellus Health on 15 of the 16 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£516K£1.70B£7.15B£2.87B
Dividend YieldN/A4.70%2.57%6.25%
P/E Ratio-0.0220.43275.25367.00
Price / Sales1.4488.98644.3489,795.38
Price / Cash0.7631.5728.4227.89
Price / Book0.015.9710.366.30
Net Income-£7.98M-£18.66M£3.50B£5.89B
7 Day PerformanceN/A-1.29%-3.31%-0.92%
1 Month PerformanceN/A1.30%-0.86%-0.47%
1 Year Performance-79.09%-14.57%23.55%19.81%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.12
flat
N/AN/A£516K£359KN/A31
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:TRLS) was last updated on 9/14/2026 by MarketBeat.com Staff.
From Our Partners